Company profile
Sales companies
Sales companies Germany
The Netherlands 
Print page
Send page
Save page
Bookmark page
STADA as homepage
International sales activities
The Netherlands
The sales company Centrafarm B.V. in Etten-Leur focuses on the sale of generics for the Dutch prescription market. STADA’s Dutch brand activities (with an emphasis on OTC products) are bundled in the sales company Healthypharm B.V. in Etten-Leur.
In the Netherlands, sales in 2010 grew by 24% to EUR 47.2 million (previous year: EUR 38.2 million). This development was significantly influenced by sales from the disposal of bulkware1) in particular to the Dutch packaging unit in Etten-Leur, which was transferred as of August 1, 2010. Adjusted, sales in the Dutch market increased by 7% in financial year 2010.
With generics, STADA generated sales in the Netherlands in the amount of EUR 25.0 million in financial year 2010 (previous year: EUR 23.9 million). This represents a share of local Group sales of 53% (previous year: 62%). With a market share of approx. 5.1% (previous year: approx. 5.8%), STADA continued to occupy position 5 in the Dutch generics market in 2010.2)
The Group generated sales in the amount of EUR 16.0 million with branded products in the Netherlands in 2010 (previous year: EUR 14.3 million). This segment thus contributed 34% (previous year: 38%) to STADA’s Dutch sales.
In the context of “STADA – build the future”, STADA transferred the Dutch packaging unit in Etten-Leur in 2010. According to the contracts agreed, the Group can draw on the capacities of the transferred unit for a transitional period at fixed costs to a variable extent determined by STADA. Within the scope of the transfer, the 113 employees were also transferred to the acquiring company.
In the first nine months of 2011 sales increased by 29% to EUR 41.3 million (1-9/2010: EUR 32.0 million).
| 1) | Reported under the Group holdings/other tem. |
| 2) | STADA estimate based on IMS Health data at ex-factory prices. |
